NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00428220 2019-06-27A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.PfizerPhase NA Completed223 enrolled 8 charts
NCT01803503 2016-06-22Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid TumorsNational University Hospital, SingaporePhase 2 Unknown80 enrolled